This federal contract award, valued at $3,155.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atorvastatin 40 mg tablets in quantities of 1,000 to support military healthcare programs. This is a delivery order contract with a firm fixed price arrangement. The contract has an ultimate completion date of July 9, 2024 and was awarded on July 8, 2024....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,039.38 Firm Fixed Price delivery order is for 4,567,490,649 units of 10 mg Atorvastatin tablets. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,593.61 firm fixed-price delivery order is for the supply of 4,563,144 units of the cardiovascular medication Atorvastatin 40 mg tablets. The contract has an ultimate completion date of December 20, 2023 and was awarded on December 19, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 1,000 units of 40 mg Atorvastatin tablets, a cardiovascular medication, at a firm fixed price of $2,847.24. The contract has a completion date of September 26, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award, valued at $1,668.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,567,600 units of Atorvastatin 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of March 18, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $1,589.39 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,564,075 units of Atorvastatin 40 mg tablets, a generic pharmaceutical product, to support military treatment programs and facilities. The contract has a firm fixed price pricing type and an ultimate completion date of March 27, 2024....
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $6,926.13 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,565,012,899 units of Atorvastatin 20 mg tablets, a cardiovascular medication, with a completion date of June 28, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,856.02 Firm Fixed Price Delivery Order contract is for the supply of 4,562,299,416 units of Atorvastatin 40 mg tablets. The contract has a completion date of September 26, 2023 and was awarded on September 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The Defense Logistics Agency (DLA) awarded a $1,584.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,651,931 units of Atorvastatin 40 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,962.80 firm fixed-price delivery order is for the supply of 1,000 tablets of Atorvastatin 20 mg, a cardiovascular medication. The award has an ultimate completion date of August 3, 2022 and was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract...